DARIOHEALTH CORP (DRIO)
US23725P2092 - Common Stock
DARIOHEALTH CORP
NASDAQ:DRIO (4/26/2024, 7:00:02 PM)
1.48
+0.01 (+0.68%)
Company Profile
DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. The company is headquartered in New York City, New York and currently employs 241 full-time employees. The company went IPO on 2013-03-08. The firm operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. DarioHealth offers digital therapeutics solutions covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health. Its products include Dario Blood Glucose Monitoring Starter Kit and Dario Blood Pressure Monitoring System. Its Dario Blood Glucose Monitoring Starter Kit is pocket-sized smartphone blood glucose meter that measure sugar levels. Its Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. The Company’s Dario mobile application, the Dario Blood sugar (glucose) meter enables to track and check blood sugar (glucose) in real-time.
Company Info
DARIOHEALTH CORP
322 W 57Th St. #33B
New York City NEW YORK 10019
P: 16466654667
CEO: Erez Raphael
Employees: 241
Website: https://shop.mydario.com/
DRIO News
3 days ago - DarioHealth Corp.Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today new research...
10 days ago - DarioHealth Corp.Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new contracts to...
18 days ago - DarioHealth Corp.Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new studies...
a month ago - DarioHealth Corp.Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new contracts to...
a month ago - InvestorPlaceDRIO Stock Earnings: DarioHealth Beats EPS, Beats Revenue for Q4 2023DRIO stock results show that DarioHealth beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
a month ago - DarioHealth Corp.DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating ResultsFull-year 2023 revenue of $20.4 million reflects a decrease from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the...
DRIO Twits
Here you can normally see the latest stock twits on DRIO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
